Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
暂无分享,去创建一个
Stefano Bonini | Paolo Fogagnolo | Gerd Geerling | Catherine Creuzot-Garcher | Rita Mencucci | Carina Koppen | Thomas Reinhard | Alessandro Lambiase | Pasquale Aragona | Maurizio Rolando | Joaquim Neto Murta | Edward Wylegala | Leonardo Mastropasqua | A. Leonardi | C. Creuzot-Garcher | W. Chao | P. Hossain | S. Rauz | E. Wylęgała | F. Malecaze | F. Mantelli | A. Lambiase | P. Rama | L. Mastropasqua | J. Németh | S. Bonini | K. Lorenz | P. Fogagnolo | F. Sinigaglia | P. Aragona | P. Robert | R. Mencucci | J. Szaflik | T. Reinhard | J. Merayo-Lloves | F. Carley | N. Bouheraoua | J. Dart | Parwez Hossain | E. Messmer | G. Geerling | François Malecaze | Flavio Mantelli | Nacim Bouheraoua | J. Murta | E. Gabison | M. F. de la Paz | L. Torrão | Jesús Merayo-Lloves | Francesco Sinigaglia | Saaeha Rauz | Andrea Leonardi | C. Koppen | Paolo Rama | J. M. Benítez del Castillo | F. Kruse | Marcello Allegretti | Fiona Carley | Maite Sainz de la Maza | Wendy Chao | Elisabeth Messmer | Jesus Montero | Claus Cursiefen | Jaime Etxebarria | Eric Gabison | Jacek P. Szaflik | Maria De La Paz | Francisco Figueiredo | Katrin Lorenz | Pierre-Yves Robert | José Benitez del Castillo | Friedrich Kruse | Jorge Alio | Ramaesh Kanna | Janos Nemeth | Luis Torrao | John Dart | M. Allegretti | J. Alio | M. Rolando | Claus Cursiefen | M. Sainz de la Maza | J. Etxebarria | J. Montero | F. Figueiredo | Ramaesh Kanna | J. Alió | Wendy Chao | J. Szaflik
[1] D. Musch,et al. Topical fibronectin ophthalmic solution in the treatment of persistent defects of the corneal epithelium. Chiron Vision Fibronectin Study Group. , 1995, American journal of ophthalmology.
[2] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[3] Stefano Bonini,et al. Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis. , 2018, Ophthalmology.
[4] F. Hefti. Neurotrophic factor therapy for nervous system degenerative diseases. , 1994, Journal of neurobiology.
[5] E. Carpel. Congenital corneal anesthesia. , 1978, American journal of ophthalmology.
[6] H. Hsu,et al. Etiologies, Quantitative Hypoesthesia, and Clinical Outcomes of Neurotrophic Keratopathy , 2015, Eye & contact lens.
[7] A. Lambiase,et al. Diagnosis and management of neurotrophic keratitis , 2014, Clinical ophthalmology.
[8] Sandeep Jain,et al. Corneal nerves in health and disease. , 2014, Survey of ophthalmology.
[9] C. Ibáñez,et al. Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in xenopus ovary , 1991, Neuron.
[10] S. Rossi,et al. Clinical applications of NGF in ocular diseases. , 2011, Archives italiennes de biologie.
[11] A. Lambiase,et al. Topical treatment with nerve growth factor for neurotrophic keratitis. , 2000, Ophthalmology.
[12] F. Kruse,et al. Corneal nerves: structure, contents and function. , 2003, Experimental eye research.
[13] A. Lambiase,et al. Topical treatment with nerve growth factor in an animal model of herpetic keratitis , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[14] F. Mantelli,et al. Congenital Corneal Anesthesia and Neurotrophic Keratitis: Diagnosis and Management , 2015, BioMed research international.
[15] F. Mantelli,et al. Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report. , 2009, Annali dell'Istituto superiore di sanita.
[16] A. Lambiase,et al. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa , 2005, Vision Research.
[17] L. Mastropasqua,et al. Understanding the Pathogenesis of Neurotrophic Keratitis: The Role of Corneal Nerves , 2017, Journal of cellular physiology.
[18] R. Smith,et al. Clearing the cornea with nerve growth factor. , 1998, The New England journal of medicine.
[19] R. Woods,et al. Clinical grading of corneal staining of non-contact lens wearers. , 2001, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[20] B Seitz,et al. [Neurotrophic keratitis]. , 2005, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.
[21] A. Lambiase,et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. , 1998, The New England journal of medicine.
[22] V. Parisi,et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma , 2009, Proceedings of the National Academy of Sciences.
[23] Alessandro Lambiase,et al. Safety and Pharmacokinetics of Escalating Doses of Human Recombinant Nerve Growth Factor Eye Drops in a Double-Masked, Randomized Clinical Trial , 2013, BioDrugs.
[24] P. Umlauf. Neuroparalytic keratitis. , 1990, Journal of the American Optometric Association.
[25] A. Lambiase,et al. Nerve growth factor therapy for corneal disease , 2012, Current opinion in ophthalmology.